148 related articles for article (PubMed ID: 19252387)
1. [Consideration on molecular imaging technology as a tool for drug research and development].
Yajima K; Nishimura S
Yakugaku Zasshi; 2009 Mar; 129(3):297-304. PubMed ID: 19252387
[TBL] [Abstract][Full Text] [Related]
2. [Molecular imaging-based early-phase and exploratory clinical research].
Watanabe Y
Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
[TBL] [Abstract][Full Text] [Related]
3. Approaches using molecular imaging technology -- use of PET in clinical microdose studies.
Wagner CC; Langer O
Adv Drug Deliv Rev; 2011 Jun; 63(7):539-46. PubMed ID: 20887762
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.
Bergström M; Grahnén A; Långström B
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873
[TBL] [Abstract][Full Text] [Related]
5. Discovery of PET radiopharmaceuticals at the academia-industry interface.
Bernard-Gauthier V; Collier TL; Liang SH; Vasdev N
Drug Discov Today Technol; 2017 Nov; 25():19-26. PubMed ID: 29233263
[TBL] [Abstract][Full Text] [Related]
6. Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.
Burt T; John CS; Ruckle JL; Vuong LT
Expert Opin Drug Deliv; 2017 May; 14(5):657-672. PubMed ID: 27564533
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
8. Trends in microdosing and other exploratory human pharmacokinetic studies for early drug development.
Oosterhuis B
Bioanalysis; 2010 Mar; 2(3):377-9. PubMed ID: 21083246
[No Abstract] [Full Text] [Related]
9. Effective use of microdosing and Positron Emission Tomography (PET) studies on new drug discovery and development.
Sugiyama Y
Drug Metab Pharmacokinet; 2009; 24(2):127-9. PubMed ID: 19430167
[No Abstract] [Full Text] [Related]
10. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery.
Zimmer L
Expert Opin Drug Discov; 2024 Feb; 19(2):161-172. PubMed ID: 37948046
[TBL] [Abstract][Full Text] [Related]
11. Imaging as a tool in drug development.
Strack T
Drugs Today (Barc); 2007 Oct; 43(10):725-36. PubMed ID: 17987225
[TBL] [Abstract][Full Text] [Related]
12. Imaging devices for use in small animals.
Koba W; Kim K; Lipton ML; Jelicks L; Das B; Herbst L; Fine E
Semin Nucl Med; 2011 May; 41(3):151-65. PubMed ID: 21440693
[TBL] [Abstract][Full Text] [Related]
13. Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development.
Burt T; Vuong LT; Baker E; Young GC; McCartt AD; Bergstrom M; Sugiyama Y; Combes R
Altern Lab Anim; 2018 Dec; 46(6):335-346. PubMed ID: 30657329
[TBL] [Abstract][Full Text] [Related]
14. Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective.
Wong H; Bohnert T; Damian-Iordache V; Gibson C; Hsu CP; Krishnatry AS; Liederer BM; Lin J; Lu Q; Mettetal JT; Mudra DR; Nijsen MJMA; Schroeder P; Schuck E; Suryawanshi S; Trapa P; Tsai A; Wang H; Wu F
Drug Discov Today; 2017 Oct; 22(10):1447-1459. PubMed ID: 28476536
[TBL] [Abstract][Full Text] [Related]
15. The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals.
Roselt P; Meikle S; Kassiou M
Eur J Drug Metab Pharmacokinet; 2004; 29(1):1-6. PubMed ID: 15151164
[TBL] [Abstract][Full Text] [Related]
16. Microdosing and drug development: past, present and future.
Lappin G; Noveck R; Burt T
Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):817-34. PubMed ID: 23550938
[TBL] [Abstract][Full Text] [Related]
17. Imaging in the cardiovascular and metabolic disease area.
Comley RA; Kallend D
Drug Discov Today; 2013 Feb; 18(3-4):185-92. PubMed ID: 23032726
[TBL] [Abstract][Full Text] [Related]
18. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
19. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
Gieschke R; Steimer JL
Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]